UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 363

Sortiert nach

Tumor suppression by the EGR1, DMP1, ARF, p53, and PTEN Network

Cancer investigation, 2018-11, Vol.36 (9-10), p.520-536

2018

Link zum Volltext

Verfügbarkeit prüfen

The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3

Nature communications, 2021-01, Vol.12 (1), p.704-19, Article 704

2021

Link zum Volltext

Verfügbarkeit prüfen

Alterations of p63 and p73 in human cancers

Sub-cellular biochemistry, 2014, Vol.85, p.17

2014

Link zum Volltext

Verfügbarkeit prüfen

Survival of Lung Cancer Patients Dependent on the LOH Status for DMP1 , ARF , and p53

International journal of molecular sciences, 2020-10, Vol.21 (21), p.7971

2020

Link zum Volltext

Verfügbarkeit prüfen

Dmp1α inhibits HER2/neu-induced mammary tumorigenesis

PloS one, 2013, Vol.8 (10), p.e77870

2013

Link zum Volltext

Verfügbarkeit prüfen

Ras-Raf-Arf Signaling Critically Depends on the Dmp1 Transcription Factor

Molecular and Cellular Biology, 2005-01, Vol.25 (1), p.220-232

2005

Link zum Volltext

Verfügbarkeit prüfen

Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance

Clinical Medicine Insights. Oncology, 2010-01, Vol.2010 (4), p.15-34

2010

Link zum Volltext

Verfügbarkeit prüfen

Induction of Transcriptionally Active Jun Proteins Regulates Drug-induced Senescence

The Journal of biological chemistry, 2006-11, Vol.281 (45), p.34475-34483

2006

Link zum Volltext

Verfügbarkeit prüfen

Recent Progress in Mouse Models for Tumor Suppressor Genes and its Implications in Human Cancer

Clinical Medicine Insights. Oncology, 2013-01, Vol.2013 (7), p.103-122

2013

Link zum Volltext

Verfügbarkeit prüfen

Positive and negative regulation of prostate stem cell antigen expression by Yin Yang 1 in prostate epithelial cell lines

PloS one, 2012-04, Vol.7 (4), p.e35570

2012

Link zum Volltext

Verfügbarkeit prüfen

Mutually Exclusive Inactivation of DMP1 and ARF/p53 in Lung Cancer

Cancer cell, 2007-10, Vol.12 (4), p.381-394

2007

Link zum Volltext

Verfügbarkeit prüfen

Novel Molecular Markers for Breast Cancer

Biomarkers in Cancer, 2016-01, Vol.2016 (8), p.25-42

2016

Link zum Volltext

Verfügbarkeit prüfen

Gene Expression and Cell Cycle Arrest Mediated by Transcription Factor DMP1 Is Antagonized by D-Type Cyclins through a Cyclin-Dependent-Kinase-Independent Mechanism

Molecular and Cellular Biology, 1998-03, Vol.18 (3), p.1590-1600

1998

Link zum Volltext

Verfügbarkeit prüfen

Transcription factors that interact with p53 and Mdm2

International journal of cancer, 2016-04, Vol.138 (7), p.1577-1585

2016

Link zum Volltext

Verfügbarkeit prüfen

Aberrant splicing of the DMP1‐ARF‐MDM2‐p53 pathway in cancer

International journal of cancer, 2016-07, Vol.139 (1), p.33-41

2016

Link zum Volltext

Verfügbarkeit prüfen

c-MYB and DMTF1 in Cancer

Cancer investigation, 2019-01, Vol.37 (1), p.46-65

2019

Link zum Volltext

Verfügbarkeit prüfen

Aberrant Expression of Cyclin D1 in Cancer

Signal Transduction Insights, 2015-01, Vol.2015 (2015), p.1-13

2015

Link zum Volltext

Verfügbarkeit prüfen

Oncogenic and tumor‐suppressive mouse models for breast cancer engaging HER2/neu

International journal of cancer, 2017-02, Vol.140 (3), p.495-503

2017

Link zum Volltext

Verfügbarkeit prüfen

Aberrant overexpression of the wilms tumor gene (WT1) in human leukemia

Blood, 1997-02, Vol.89 (4), p.1405-1412

1997

Link zum Volltext

Verfügbarkeit prüfen

Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas

Genes & development, 2001-11, Vol.15 (22), p.2934-2939

2001

Link zum Volltext

Verfügbarkeit prüfen

Induction of ARF Tumor Suppressor Gene Expression and Cell Cycle Arrest by Transcription Factor DMP1

Proceedings of the National Academy of Sciences - PNAS, 1999-03, Vol.96 (7), p.3993-3998

1999

Link zum Volltext

Verfügbarkeit prüfen

Transgenic and Knockout Mice Models to Reveal the Functions of Tumor Suppressor Genes

Clinical Medicine Insights. Oncology, 2011-01, Vol.2011 (5), p.235-257

2011

Link zum Volltext

Verfügbarkeit prüfen

Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu: Mouse models for BC engaging HER2/neu

International journal of cancer, 2017-02, Vol.140 (3), p.495-503

2017

Link zum Volltext

Verfügbarkeit prüfen

DNA Damage-Dependent Translocation of B23 and p19ARF Is Regulated by the Jun N-Terminal Kinase Pathway

Cancer research (Chicago, Ill.), 2008-03, Vol.68 (5), p.1398-1406

2008

Link zum Volltext

Verfügbarkeit prüfen

Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis

Genes & development, 2000-07, Vol.14 (14), p.1797-1809

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 363

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(292)
Mit Volltextzugriff
(322)

Publikationsform

Sprache

Englisch
(342)
Japanisch
(114)
Deutsch
(1)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Tumor suppression by the EGR1, DMP1, ARF, p53, and PTEN Network

The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3

Alterations of p63 and p73 in human cancers

Survival of Lung Cancer Patients Dependent on the LOH Status for DMP1 , ARF , and p53

Dmp1α inhibits HER2/neu-induced mammary tumorigenesis

Ras-Raf-Arf Signaling Critically Depends on the Dmp1 Transcription Factor

Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance

Induction of Transcriptionally Active Jun Proteins Regulates Drug-induced Senescence

Recent Progress in Mouse Models for Tumor Suppressor Genes and its Implications in Human Cancer

Positive and negative regulation of prostate stem cell antigen expression by Yin Yang 1 in prostate epithelial cell lines

Mutually Exclusive Inactivation of DMP1 and ARF/p53 in Lung Cancer

Novel Molecular Markers for Breast Cancer

Gene Expression and Cell Cycle Arrest Mediated by Transcription Factor DMP1 Is Antagonized by D-Type Cyclins through a Cyclin-Dependent-Kinase-Independent Mechanism

Transcription factors that interact with p53 and Mdm2

Aberrant splicing of the DMP1‐ARF‐MDM2‐p53 pathway in cancer

c-MYB and DMTF1 in Cancer

Aberrant Expression of Cyclin D1 in Cancer

Oncogenic and tumor‐suppressive mouse models for breast cancer engaging HER2/neu

Aberrant overexpression of the wilms tumor gene (WT1) in human leukemia

Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas

Induction of ARF Tumor Suppressor Gene Expression and Cell Cycle Arrest by Transcription Factor DMP1

Transgenic and Knockout Mice Models to Reveal the Functions of Tumor Suppressor Genes

Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu: Mouse models for BC engaging HER2/neu

DNA Damage-Dependent Translocation of B23 and p19ARF Is Regulated by the Jun N-Terminal Kinase Pathway

Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis

Suchergebnisse filtern